Rifaximin Use Linked to Increased Antimicrobial Resistance Risk
Recent multinational research reveals an increased risk of antimicrobial resistance among cirrhosis patients treated with rifaximin, while in vitro pharmacodynamic models have…
Recent multinational research reveals an increased risk of antimicrobial resistance among cirrhosis patients treated with rifaximin, while in vitro pharmacodynamic models have…